Patent · US Active

Method for treating amyloid disease

US9295719B2 · kind B2 · utility

0Cited by
19References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 3, 2014
Grant dateMar 29, 2016
Priority date
Expiry dateDec 3, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/58
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to methods for treating human amyloid disease by administration of modified Aβ peptide immunogens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.